The Membership Committee is responsible for establishing the criteria for initial and ongoing membership in NRG Oncology for submission to and final approval by the Group Chairs. The committee is responsible for developing application forms; reviewing and evaluating applications and re-applications; monitoring patient accrual; evaluating compliance with required data submissions; evaluating the quality assurance audits; visiting member sites as necessary for evaluation; making recommendations to the Group Chairs regarding a Member Institution’s initial or continued participation in NRG Oncology, and such other responsibilities or delegated by the Group Chairs. The Committee makes recommendations to the Group Chairs regarding the acceptance of an application or termination of a member based upon its reviews. The committee oversees the NCI-mandated on-site audit program, supervises the documentation of the accuracy of the data submitted to NRG, verifies investigator compliance with regulatory and group requirements for clinical trials, and investigates alleged conflict of interest and scientific misconduct. The Committee considers and adjudicates appeals and/or disputes related to membership and will issue recommendations to the Group Chairs for final decisions. The Committee also supports the Canadian, International, and Veterans Administration/Military Treatment Facilities Subcommittees.
The Membership Committee meets during the semiannual Group meeting and may have interim meetings determined by the needs of the Group. The Committee is comprised of no more than 15 Member Institution representatives and shall include a balance of medical disciplines representing appointees by the Group Chairs. The committee is chaired by the Deputy Group Chair for Membership and Research Integrity.